# TracelT Hydrogel in Localizing Bladder Tumors in Patients Undergoing Radiation Therapy for Bladder Cancer

> **NCT03125226** · NA · COMPLETED · sponsor: **University of Washington** · enrollment: 12 (actual)

## Conditions studied

- Bladder Carcinoma

## Interventions

- **DEVICE:** Polyethylene Glycol Hydrogel

## Key facts

- **NCT ID:** NCT03125226
- **Lead sponsor:** University of Washington
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-10-05
- **Primary completion:** 2020-01-01
- **Final completion:** 2020-05-18
- **Target enrollment:** 12 (ACTUAL)
- **Last updated:** 2021-02-25

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03125226

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03125226, "TracelT Hydrogel in Localizing Bladder Tumors in Patients Undergoing Radiation Therapy for Bladder Cancer". Retrieved via AI Analytics 2026-05-30 from https://api.ai-analytics.org/clinical/NCT03125226. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*